- Identification of phthalates in medications and dietary supplement formulations in the United States and CanadaKatherine E Kelley
Slone Epidemiology Center at Boston University, Boston, Massachusetts 02215, USA
Environ Health Perspect 120:379-84. 2012..Limited evidence suggests that particularly high exposure levels may result from orally ingested medicinal products containing phthalates as excipients (inactive ingredients)...
- Medications as a potential source of exposure to phthalates in the U.S. populationSonia Hernandez-Diaz
Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA
Environ Health Perspect 117:185-9. 2009..Underappreciated sources of exposure include phthalates in the polymers coating some oral medications...
- Medications as a potential source of exposure to phthalates among women of childbearing ageSonia Hernandez-Diaz
Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
Reprod Toxicol 37:1-5. 2013..To evaluate the association between the use of medications potentially containing phthalates and urinary concentrations of specific phthalate metabolites around conception...
- Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008Allen A Mitchell
Slone Epidemiology Center at Boston University, Boston, MA, USA
Am J Obstet Gynecol 205:51.e1-8. 2011..The objective of the study was to provide information on overall medication use throughout pregnancy, with particular focus on the first trimester and specific prescription medications...